Skip to Content

Endava PLC ADR

DAVA: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$46.00KtbvvdWjxwtlf

Endava Earnings: Cutting Fair Value 20% on Weak Outlook and GalaxE Acquisition; Shares Undervalued

Narrow-moat Endava shares declined 42% on a weak outlook, and it announced the acquisition of GalaxE Solutions, the largest in Endava's history ($405 million or 10% of the market cap). We’ve cut our fair value by 20% to $62, primarily due to reducing our revenue growth forecast. We’ve delayed our expected cyclical recovery to fiscal 2025 (June year-end) from fiscal 2024. Excluding the GalaxE acquisition, we now expect five-year revenue growth CAGR of 8.9% versus 13.8% previously. We see the GalaxE acquisition as broadly neutral to our valuation. Overall, we think the market has overreacted, with shares trading at a 40% discount to our fair value estimate. However, with serious doubts over the path of revenue recovery now, several quarters of positive results will be needed to regain investor confidence.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of DAVA so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center